Anemia
📧 Sign up to get email alerts when something new happens for Anemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa [Phase 2]
Phase 2 clinical trial evaluating vadadustat in hemodialysis patients with anemia switching from epoetin alfa has completed; results posted …
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: IV Iron Safety: Evaluation of Iron Species in Healthy Subjects [Phase 4]
Phase 4 trial evaluating iron species safety in healthy subjects to compare iron formulations.
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone [Phase 2]
Phase 2 clinical trial update on chelation therapy using Pyridoxal Isonicotinoyl Hydrazone for iron overload in anemia due to beta-thalassem…
-
CLINICAL_TRIALS trial_result · 2022-08-19Clinical Trial Update: Management of Preoperative Anaemia in Surgical Oncology [Phase 4]
A Phase 4 clinical trial update addressing management of preoperative anemia in patients undergoing surgical oncology.
-
CLINICAL_TRIALS trial_result · 2022-07-18Clinical Trial Update: Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Participants With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD) [Phase 3]
Phase 3 trial evaluating vadadustat for correction or maintenance treatment of anemia in incident dialysis-dependent CKD; study completed wi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Utility of Non-invasive Carboxyhemoglobin and Total Hemoglobin Measurement in the Emergency Department
A terminated clinical trial evaluating non-invasive carboxyhemoglobin and total hemoglobin measurement in the emergency department for carbo…
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: 20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia [Phase 2]
Phase 2 trial update for AKB-6548 in adults with chronic kidney disease and anemia; study completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: 42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia [Phase 2]
Phase 2 trial update for AKB-6548 in chronic kidney disease with anemia; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia [Phase 2]
Phase 2 clinical trial assessing safety and efficacy of AKB-6548 in adults with chronic kidney disease and anemia has completed, with result…
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: 16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis [Phase 2]
Phase 2 clinical trial update for AKB-6548 in anemia associated with end-stage renal disease requiring hemodialysis has completed with resul…
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD) [Phase 3]
Phase 3 study evaluating vadadustat for maintenance treatment of anemia in dialysis-dependent CKD completed with posted results in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-27Clinical Trial Update: Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease [Phase 3]
Phase 3 trial evaluating vadadustat for correction of anemia in non-dialysis-dependent chronic kidney disease has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2022-06-27Clinical Trial Update: Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) [Phase 3]
Phase 3 trial evaluating vadadustat for maintenance treatment of anemia in non-dialysis-dependent chronic kidney disease completed with post…
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND) [Phase 3]
Phase 3 trial update for daprodustat in non-dialysis chronic kidney disease patients with anemia; study completed with results posted in 202…
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Effect of Intravenous Tranexamic Acid on Reduction of Blood Losses in Hip Fracture Patients [Phase 4]
Phase 4 clinical trial evaluating intravenous tranexamic acid to reduce blood loss in hip fracture patients with anemia; study completed.
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients [Phase 3]
Phase 3 trial comparing ferumoxytol to oral iron for anemia in hemodialysis patients has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-07Clinical Trial Update: Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis. [Phase 2]
Phase 2 trial assessing the optimal starting subcutaneous dose of Mircera for maintenance treatment of anemia in pediatric chronic kidney di…
-
CLINICAL_TRIALS trial_result · 2022-02-11Clinical Trial Update: Transfusion of Prematures Trial [NA]
The NICHD Neonatal Research Network reports that the Transfusion of Prematures trial (NCT01702805) has completed and posted results, studyin…
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia [Phase 2]
Phase 2 study of Roxadustat in non-dialysis chronic kidney disease patients with anemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal Failure [Phase 3]
Phase III clinical study investigating recombinant erythropoiesis-stimulating protein (rESP) for anemia in patients with chronic kidney dise…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis [Phase 2]
Phase 2 study of Roxadustat (FG-4592) in patients with end-stage renal disease on maintenance hemodialysis has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: XIENCE 28 USA Study [NA]
Clinical trial update for XIENCE 28 USA study has completed with results posted in December 2021.
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy [NA]
A completed clinical trial evaluating intravenous ferric carboxymaltose for treating anemia in cancer patients undergoing chemotherapy, with…
-
CLINICAL_TRIALS trial_result · 2021-12-03Clinical Trial Update: Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) [Phase 3]
Phase 3 trial update for daprodustat (a novel prolyl hydroxylase inhibitor) in anemia of chronic kidney disease (ASCEND-D) has completed wit…
-
CLINICAL_TRIALS trial_result · 2021-12-02Clinical Trial Update: Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control Trial [Phase 2]
Phase 2 trial investigating erythropoietin to prevent unnecessary transfusions in patients with cyanotic congenital heart disease; study ter…